This inventor holds 1 USPTO granted patent. Top assignee: Daegu-Gyeongbuk Medical Innovation Foundation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Oh Bin Kwon: Innovator in Cancer Treatment
Introduction
Oh Bin Kwon is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work focuses on developing compositions that can effectively combat cancer.
Latest Patents
Oh Bin Kwon holds a patent for a pharmaceutical composition comprising trimebutine or its pharmaceutically acceptable salt as an active ingredient for the prevention or treatment of cancer. This invention is particularly noteworthy as it selectively inhibits the growth and proliferation of cancer stem cells. The composition has shown promise in suppressing the recurrence, metastasis, and progression of cancer, making it a valuable asset in cancer therapy.
Career Highlights
Kwon is associated with the Daegu-Gyeongbuk Medical Innovation Foundation, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving cancer treatment options and enhancing patient outcomes.
Collaborations
He collaborates with esteemed colleagues, including Jun Woo Kim and Sang Hyun Min, to further his research initiatives. Their combined expertise contributes to the innovative environment at the foundation.
Conclusion
Oh Bin Kwon's contributions to cancer treatment through his patented pharmaceutical composition highlight his role as a leading inventor in the medical field. His work not only showcases innovation but also offers hope for improved cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile